EndoKor
ActiveEndoKor has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €69k and a net result of €315k. Equity remains stable across the filed fiscal years (±0.7% per year). Its solvency ranks better than 18% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
70
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency42▼-2
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity short (current ratio 0.71 against 0.65 in 2024; short-term debt: 82.9% and cash: 18.9% of total assets), and 82.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
17.1%
Return on assets
78.5%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 16527 sector peers (2025).
NBB · sector comparisonPosition among 16527 sector peers
Solvency
better than 18%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 21-03-2026, 132 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
132 d early
2024
1 d early
2023
7 d early
2022
3 d late
2021
43 d late
2020
11 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€69k▼ 0.4%
2024 · €69k
2020: €69k
2021: €139k
2022: €114k
2023: €69k
2024: €69k
2020 → 2025
Total assets
€402k▲ 8.6%
2024 · €370k
2020: €89k
2021: €242k
2022: €384k
2023: €399k
2024: €370k
2020 → 2025
Net result
€315k▲ 10.6%
2024 · €285k
2020: €66k
2021: €108k
2022: €150k
2023: €243k
2024: €285k
2020 → 2025
Working capital
€-97k▲ 8.8%
2024 · €-106k
2020: €67k
2021: €107k
2022: €21k
2023: €-25k
2024: €-106k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€139k-€114k▼ 18.3%€69k▼ 39.2%€69k▼ 0.7%€69k▼ 0.4%
Operating result€136k-€195k▲ 42.8%€322k▲ 65.3%€369k▲ 14.7%€414k▲ 12.2%
Net result€108k-€150k▲ 37.9%€243k▲ 62.8%€285k▲ 17.1%€315k▲ 10.6%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 12% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €402k
Fixed assets
€166k▼ 5.5%
Current assets
€236k▲ 21.3%
Equity and liabilities €402k
Equity
€69k▼ 0.4%
Debt
€333k▲ 10.7%
The debt ratio rises from 81.4% to 82.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€443k▲
2024 · €389k
Cash flow
€345k▲
2024 · €305k
Solvency
17.1%▼
2024 · 18.6%
Current ratio
0.71▲
2024 · 0.65
Quick ratio
0.71▲
2024 · 0.65
Debt / equity
4.86▲
2024 · 4.37
ROE
459.5%▲
2024 · 413.8%
ROA
78.5%▲
2024 · 77.1%
Interest coverage
1492.05▼
2024 · 1716.05
Debt
€333k▲
2024 · €301k
Debt ≤ 1 year
€333k▲
2024 · €301k
Income taxes
€101k▲
2024 · €93k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€370k€402k▲
Fixed assets21/28€175k€166k▼
Tangible fixed assets22/27€175k€166k▼
Land and buildings22€52k€59k▲
Plant, machinery and equipment23€4k€5k▲
Furniture and vehicles24€119k€102k▼
Current assets29/58€195k€236k▲
Amounts receivable within one year40/41€9k€7k▼
Trade receivables40-€1k
Other amounts receivable41€9k€6k▼
Current investments50/53-€150k
Cash at bank and in hand54/58€184k€76k▼
Deferred charges and accrued income490/1€2k€3k▲
Equity and liabilities
Total equity and liabilities10/49€370k€402k▲
Equity10/15€69k€69k▼
Contributions10/11€3k€3k=
Reserves13€66k€66k=
Distributable reserves133€66k€66k=
Profit (loss) carried forward14€373€84▼
Amounts payable17/49€301k€333k▲
Amounts payable within one year42/48€301k€333k▲
Trade debts44€6k€9k▲
Suppliers440/4€6k€9k▲
Taxes, remuneration and social security45€10k€8k▼
Taxes450/3€10k€8k▼
Other amounts payable47/48€286k€316k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20k€29k▲
Other operating charges640/8€236-
Gross operating margin9900€389k€443k▲
Operating profit (loss)9901€369k€414k▲
Financial income75/76B€9k€3k▼
Recurring financial income75€9k€3k▼
Financial charges65/66B€227€297▲
Recurring financial charges65€227€297▲
Profit (loss) for the period before taxes9903€378k€416k▲
Income taxes67/77€93k€101k▲
Profit (loss) for the period9904€285k€315k▲
Profit (loss) for the period to be appropriated9905€285k€315k▲
Appropriation of the result
Profit (loss) to be appropriated9906€286k€316k▲
Profit (loss) brought forward from the previous period14P€842€373▼
Profit to be distributed694/7€286k€316k▲
Return on contributions (dividend)694€286k€316k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
21-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €315k ▲10.6%
Operating result €414k, net result €315k, both a record.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
03-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 3 days late
2022
12-09
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 43 days late
2021
31-12
Financial
Equity above €100kEq €139k ▲104%
2 profitable years in a row build equity to €139k.
11-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Holsbeek · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sint-Geertruibos 123220 HolsbeekGround area
1,987 m²
Building footprint
161 m²
Volume, LiDAR
614 m³
Parcel 24043F0067/00B004, Flanders · tallest building 24.2 m. Linked by address, not a title deed.
1 establishment unit
EndoKor
since 20202.300.564.935
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24043F0067/00B004 | Flanders | 1,987 m² | 1 · 161 m² | 24.2 m |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. DENOISEUX
BE 0898.030.651
Saint-Nicolas · Eq €69k
DRLEGRANDANAIS
BE 0775.756.807
Gerpinnes · Eq €69k
Dokter Nathalie Coosemans
BE 1002.392.555
Zoersel · Eq €68k
AZGAS MEDICAL
BE 0798.895.463
Sint-Lambrechts-Woluwe · Eq €68k
DOCTEUR MARTIN MOÏSE
BE 0775.306.746
Esneux · Eq €69k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 5,672 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-03-2020
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.